Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
在真实世界数据集中对 1652 例早期 ER 阳性、HER2 阴性乳腺癌进行风险评估的比较：经典病理参数与 12 基因分子检测 (EndoPredict)
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06415-0
Jank, Paul; Lindner, Judith Lea; Lehmann, Annika; Pfitzner, Berit Maria; Blohmer, Jens-Uwe; Horst, David; Kronenwett, Ralf; Denkert, Carsten; Schmitt, Wolfgang Daniel
